Homology modeling and antagonist binding site study of the human histamine H2 receptor

Medicinal Chemistry

Volumn 8, Issue 6, 2012, Pages 1084-1092

  Zhang, Jing ^a   Qi, Tao ^a   Wei, Jing ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Antagonists; Binding site; Homology modeling; Human histamine H2 receptor; Molecular docking; Molecular dynamics

Indexed keywords

ADENOSINE A2 RECEPTOR; ASPARTIC ACID; BETA 2 ADRENERGIC RECEPTOR; CIMETIDINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; RANITIDINE; RHODOPSIN;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DRUG DESIGN; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MUTAGENESIS; PRIORITY JOURNAL;

ANIMALS; BINDING SITES; CATTLE; DRUG DESIGN; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN BONDING; MOLECULAR DYNAMICS SIMULATION; MUTAGENESIS; PROTEIN CONFORMATION; RECEPTORS, HISTAMINE H2; SEQUENCE HOMOLOGY, AMINO ACID; THERMODYNAMICS;

EID: 84868015949     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411208061084     Document Type: Article

References (65)

1. Parsons, M.E.; Ganellin, C.R. Histamine and its receptors. Br. J. Pharmacol., 2006, 147, S127-S135.
2. Kwan, H.Y.; Wong, C.O.; Chen, Z.Y.; Dominic Chan, T.W.; Huang, Y.; Yao, X. Stimulation of histamine H2 receptors activates TRPC3 channels through both phospholipase C and phospholipase D. Eur. J. Pharmacol., 2009, 602, 181-187.
3. Thurmond, R.L.; Gelfand, E.W.; Dunford, P.J. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat. Rev. Drug Discov., 2008, 7, 41-53.
4. DelValle, J.; Gantz, I. Novel insights into histamine H2 receptor biology. Am. J. Physiol., 1997, 273, G987-G996.
5. Burland, W.L.; Duncan, W.A.; Hesselbo, T.; Mills, J.G.; Sharpe, P.C.; Haggie, S.J.; Wyllie, J.H. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br. J. Clin. Pharmacol., 1975, 2, 481-486.
6. Bradshaw, J.; Brittain, R.T.; Clitherow, J.W.; Daly, M. J.; Jack, D.; Price, B. J.; Stables, R. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist. Br. J. Pharmacol., 1979, 66, 464P.
7. Valenzuela, J.E.; Strecker, R.B.; Douglas, A.P. Tiotidine, a new H2-receptor antagonist, is a potent inhibitor of nocturnal acid secretion in duodenal ulcer patients. Dig. Dis. Sci., 1981, 26, 433-437.
8. Howard, J.M.; Chremos, A.N.; Collen, M.J.; McArthur, K.E.; Cherner, J.A.; Maton, P.N.; Ciarleglio, C.A.; Cornelius, M.J.; Gardner, J.D.; Jensen, R.T. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology, 1985, 88, 1026-1033.
9. Price, A.H.; Brogden, R.N. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs, 1988, 36, 521-539.
10. Krieger, E.; Nabuurs, S.B.; Vriend, G. Homology modeling. Methods Biochem. Anal., 2003, 44, 509-523.
11. Patny, A.; Desai, P.V.; Avery, M.A. Homology modeling of Gprotein- coupled receptors and implications in drug design. Curr. Med. Chem., 2006, 13, 1667-1691.
12. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Trong, I.L.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science, 2000, 289, 739-745.
13. Cherezov, V.; Rosenbaum, D.M.; Hanson, M.A.; Søren, G.F.R.; Thian, F.S.; Kobilka, T.S.; Choi, H.J.; Kuhn, P.; Weis, W.I.; Kobilka, B. K.; Stevens, R.C. High-resolution crystal structure of an engineered human 2-adrenergic G protein-coupled receptor. Science, 2007, 318, 1258-1265.
14. Jaakola, V.P.; Griffith, M.T.; Hanson, M.A.; Cherezov, V.; Chien, E.Y.T.; Lane, J.R.; IJzerman, A.P.; Stevens, R.C. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science, 2008, 322, 1211-1217.
15. Li, G.; Haney, K.M.; Kellogg, G.E.; Zhang, Y. Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models. J. Chem. Inf. Model., 2009, 49, 120-132.
16. Kneissl, B.; Leonhardt, B.; Hildebrandt, A.; Tautermann, C.S. Revisiting automated G-protein coupled receptor modeling: the benefit of additional template structures for a neurokinin-1 receptor model. J. Med. Chem., 2009, 52, 3166-3173
17. Kanagarajadurai, K.; Malini, M.; Bhattacharya, A.; Panicker, M.M.; Sowdhamini, R. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding. Mol. Biosyst., 2009, 5, 1877-1888.
18. McRobb, F.M.; Capuano, B.; Crosby, I.T.; Chalmers, D.K.; Yuriev, E. Homology modeling and docking evaluation of aminergic G protein-coupled receptors. J. Chem. Inf. Model., 2010, 50, 626-637.
19. Ben, D.D.; Antonini, I.; Buccioni, M.; Lambertucci, C.; Marucci, G.; Vittori, S.; Volpini, R.; Cristalli, G. Molecular modeling studies on the human neuropeptide S receptor and its antagonists. ChemMedChem., 2010, 5, 371-383.
20. Chou, K.C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134.
21. Chou, K.C. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. Biochem. Biophys. Res. Comm., 2004, 316, 636-642.
22. Chou, K.C. Molecular therapeutic target for type-2 diabetes. J. Proteome Res., 2004, 3, 1284-1288.
23. Chou, K.C.; Wei, D.Q.; Zhong, W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
24. He, Z.S.; Zhang, J.; Shi, X.H.; Hu, L.L.; Kong, X.G.; Cai, Y.D.; Chou, K.C. Predicting drug-target interaction networks based on functional groups and biological features. PLoS One, 2010, 5, e9603.
25. Chou, K.C.; Wei, D.Q.; Du, Q.S.; Sirois, S.; Zhong, W.Z. Review: Progress in computational approach to drug development against SARS. Curr. Med. Chem., 2006, 13, 3263-3270.
26. Chou, K.C.; Shen, H.B. Cell-PLoc: A package of Web servers for predicting subcellular localization of proteins in various organisms. Nat. Protocols, 2008, 3, 153-162.
27. Chou, K.C.; Shen, H.B. Review: Recent progresses in protein subcellular location prediction. Anal. Biochem., 2007, 370, 1-16.
28. Chou, K.C.; Shen, H.B. A new method for predicting the subcellular localization of eukaryotic proteins with both single and multiple sites: Euk-mPLoc 2.0. PLoS One, 2010, 5, e9931.
29. Chou, K.C.; Shen, H.B. Cell-PLoc 2.0: An improved package of web-servers for predicting subcellular localization of proteins in various organisms. Nat. Sci., 2010, 2, 1090-1103.
30. Xiao, X.; Wang, P.; Chou, K.C. GPCR-CA: A cellular automaton image approach for predicting G-protein-coupled receptor functional classes. J. Comput. Chem., 2009, 30, 414-1423.
31. Chou, K.C. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem., 1993, 268, 16938-16948.
32. Chou, K.C. Review: Prediction of HIV protease cleavage sites in proteins. Anal. Biochem., 1996, 233,1-14.
33. Chou, K.C.; Shen, H.B. Signal-CF: a subsite-coupled and windowfusing approach for predicting signal peptides. Biochem. Biophys. Res. Comm., 2007, 357, 633-640.
34. Ginalski, K. Comparative modeling for protein structure prediction. Curr. Opin. Struct. Biol., 2006, 16, 172-177.
35. Xiang, Z. Advances in homology protein structure modeling. Curr. Protein Pept. Sci., 2006, 7, 217-227.
36. Chenna, R.; Sugawara, H.; Koike, T.; Lopez, R.; Gibson, T.J.; Higgins, D.G.; Thompson, J.D. Multiple sequence alignment with the clustal series of programs. Nucleic Acids Res., 2003, 31, 3497-3500.
37. Fiser, A.; Sali, A. Modeller: generation and refinement of homology- based protein structure models. Methods Enzymol., 2003, 374, 461-491.
38. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr., 1993, 26, 283-291.
39. Colovos, C.; Yeates, T.O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci., 1993, 2, 1511-1519.
40. Baker, J.G. A study of antagonist affinities for the human histamine H2 receptor. Br. J. Pharmacol., 2008, 153, 1011-1021.
41. Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huer, R.; Hart, W.E.; Belew, R.K.; Oloson, A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 1998, 19, 1639-1662.
42. Case, D.A.; Cheatham III, T.E.; Darden, T.; Gohlke, H.; Luo, R.; Merz JR., K.M.; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R.J. The amber biomolecular simulation programs. J. Comput. Chem., 2005, 26, 1668-1688.
43. Wang, J.; Wolf, R.M.; Caldwell, J.W.; Kollman, P.A.; Case, D.A. Development and testing of a general amber force field. J. Comput. Chem., 2004, 25, 1157-1174.
44. Ryckaert, J.; Ciccotti, G.; Berendsen, H. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys., 1977, 23, 327-341.
45. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N-log (N) method for Ewald sums in large systems. J. Chem. Phys., 1993, 98, 10089-10092.
46. Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem., 2000, 43, 4759-4767.
47. Wang, R.; Lu, Y.; Wang, S. Comparative evaluation of 11 scoring functions for molecular docking. J. Med. Chem., 2003, 46, 2287-2303.
48. Yan, C.; Xiu, Z.; Li, X.; Li, S.; Hao, C.; Teng, H. Comparative molecular dynamics simulations of histone deacetylase-like protein: Binding modes and free energy analysis to hydroxamic acid inhibitors. Proteins, 2008, 73, 134-149.
49. Forrest, L.R.; Tang, C.L.; Honig, B. On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins. Biophys. J., 2006, 91, 508-517.
50. Larsson, P.; Wallner, B.; Lindahl, E.; Elofsson, A. Using multiple templates to improve quality of homology models in automated homology modeling. Protein Sci., 2008, 17, 990-1002.
51. Cheng, J. A multi-template combination algorithm for protein comparative modeling. BMC Struct. Biol., 2008, 8, 18.
52. Chou, K.C.; Watenpaugh, K.D.; Heinrikson, R.L. A model of the complex between cyclin-dependent kinase 5 (Cdk5) and the activation domain of neuronal Cdk5 activator. Biochem. Biophys. Res. Comm., 1999, 259, 420-428.
53. Zhang, J.; Luan, C.H.; Chou, K.C.; Johnson G.V.W. Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling. Proteins, 2002, 48, 447-453.
54. Chou, K.C. Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. Biochem. Biophys. Res. Comm., 2004, 319, 433-438.
55. Wei, D.Q.; Du, Q.S.; Sun, H.; Chou, K.C. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. Biochem. Biophys. Res. Comm., 2006, 344, 1048-1055.
56. Wei, J.; Li, H.; Qu, W.; Gao, Q. Molecular docking study of A3 adenosine receptor antagonists and pharmacophore-based drug design. Neurochem. Int., 2009, 55, 637-642.
57. Du, Q.S.; Sun, H.; Chou, K.C. Inhibitor design for SARS coronavirus main protease based on "distorted key theory". Med. Chem., 2007, 3, 1-6.
58. Housaindokht, M.R.; Bozorgmehr, M.R.; Bahrololoom, M. Analysis of ligand binding to proteins using molecular dynamics simulations. J. Theor. Biol., 2008, 254, 294-300.
59. Wang, J.F.; Wei, D.Q.; Li, L.; Zheng, S.Y.; Li, Y.X.; Chou, K.C. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochem. Biophys. Res. Commun., 2007, 355, 513-519.
60. Liao, Q.H.; Gao, Q.Z.; Wei, J.; Chou, K.C. Docking and molecular dynamics study on the inhibitory activity of novel inhibitors on epidermal growth factor receptor (EGFR). Med. Chem., 2011, 7, 24-31.
61. Thangapandian, S.; Krishnamoorthy, N.; John, S.; Sakkiah, S.; Lazar, P.; Lee, Y.; Lee, K.W. Pharmacophore modeling, virtual screening and molecular docking studies for identification of new inverse agonists of human histamine H1 receptor. Bull. Korean Chem. Soc., 2010, 31, 52-58.
62. Kiss, R.; Kovária, Z.; Keser-, G.M. Homology modelling and binding site mapping of the human histamine H1 receptor. Eur. J. Med. Chem., 2004, 39, 959-967.
63. Gantz, I.; DelValle, J.; Wang, L.D.; Tashiro, T.; Munzert, G.; Guo, Y.J.; Konda, Y.; Yamada, T. Molecular basis for the interaction of histamine with the histamine H2 receptor. J. Biol. Chem., 1992, 267, 20840-20843.
64. Sun, X.; Li, Y.; Li, W.; Xu, Z.; Tang, Y. Computational investigation of interactions between human H2 receptor and its agonists. J. Mol. Graphics Modell., 2011, 29, 693-701.
65. Chou, K.C. Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134.